Malignant ovarian germ cell tumours: a trial of 36 cases;Tumeurs germinales malignes de l'ovaire. À propos de 36 cas

Gynecologie Obstetrique et Fertilite

Volumn 35, Issue 5, 2007, Pages 406-419

  Gueye, A ^a   Narducci, F ^b   Baranzelli, M C ^b   Collinet, P ^a   Farine, O ^a   Fournier, C ^b   Vinatier, D ^a   Leblanc, E ^b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b CENTRE OSCAR LAMBRET   (France)

Author keywords

Chemotherapy; Conservative surgery; Malignant ovarian germ cell tumour; Surgical staging

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; IFOSFAMIDE; ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CHORIOCARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DYSGERMINOMA; FEMALE; GERM CELL TUMOR; HUMAN; MEDICAL LITERATURE; OVARY CANCER; OVARY TERATOMA; ADJUVANT CHEMOTHERAPY; ADOLESCENT; CHILD; FEMALE INFERTILITY; METHODOLOGY; MIDDLE AGED; NEOPLASM; OVARIECTOMY; OVARY TUMOR; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; CHILD; FEMALE; HUMANS; INFERTILITY, FEMALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; OVARIAN NEOPLASMS; OVARIECTOMY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 34247620195     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/j.gyobfe.2007.01.028     Document Type: Article

References (45)

1. Lu K.H., and Gershenson D.M. Update on the management of ovarian germ cell tumors. J. Reprod. Med. 50 6 (2005) 417-425
2. Tewari K., Cappuccini F., Disaia P.J., et al. Malignant germ cell tumors of the ovary. Obstet. Gynecol. 95 1 (2000) 128-133
3. Talerman A. In: Kurman R. (Ed). Germ cell tumors of the ovary, in Blaustein's pathology of the female genital tract (1987), Springer-Verlag, New York 849-914
4. Williams S.H., and Silva E. In: H.R. WJPC, and Young (Ed). Ovarian germ-cell tumors., in Principles and Practice of Gynecologic Oncology (2000), Lippincott Williams and Wilkins, Philadelphia 1059-1074 (CJ)
5. Baranzelli M.C., Patte C., Bouffet E., et al. [Malignant non-seminomatous germinal tumors of the ovary. Experience of the French Society of Pediatric Oncology. 64 cases]. Contracept. Fertil. Sex. 27 2 (1999) 133-139
6. Changes in definitions of clinical staging for carcinoma of the cervix and ovary: International Federation of Gynecology and Obstetrics. Am. J. Obstet. Gynecol. 156 1 (1987) 263-264
7. Smith J.P., and Rutledge F. Advances in chemotherapy for gynecologic cancer. Cancer 36 2 (1975) 669-674
8. Droz, JP. Les tumeurs germinales : le point de vue du clinicien. In Carrefour pathologie 2005. 2005.
9. Gershenson D.M. Update on malignant ovarian germ cell tumors. Cancer 71 4 Suppl. (1993) 1581-1590
10. Williams S.D., Blessing J.A., DiSaia P.J., et al. Second-look laparotomy in ovarian germ cell tumors: the gynecologic oncology group experience. Gynecol. Oncol. 52 3 (1994) 287-291
11. Williams S., et al. Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group. J. Clin. Oncol. 12 4 (1994) 701-706
12. Serov S.F.S.R., and Sobin L.J. Histological typing of ovarian tumors. In:World Heath Organisation. International histological classification of tumors (1973), World Health Organisation, Geneva
13. Norris H.J., Zirkin H.J., and Benson W.L. Immature (malignant) teratoma of the ovary: a clinical and pathologic study of 58 cases. Cancer 37 5 (1976) 2359-2372
14. Morice P., Leblanc E., Rey A., et al. Conservative treatment in epithelial ovarian cancer: results of a multicentre study of the GCCLCC (Groupe des chirurgiens du centre de lutte contre le cancer) and SFOG (Société francaise d'oncologie gynecologique). Hum. Reprod. 20 5 (2005) 1379-1385
15. Schwartz P.E., et al. Ovarian germ cell malignancies: the Yale University experience. Gynecol. Oncol. 45 1 (1992) 26-31
16. Peccatori F., et al. Surgical management of malignant ovarian germ-cell tumors: 10 years' experience of 129 patients. Obstet. Gynecol. 86 3 (1995) 367-372
17. Brewer M., et al. Outcome and reproductive function after chemotherapy for ovarian dysgerminoma. J. Clin. Oncol. 17 9 (1999) 2670-2675
18. Messing M.J., Gershenson D.M., Morris M., et al. Primary treatment failure in patients with malignant ovarian germ cell neoplasms. Int. J. Gynecol. Cancer 2 6 (1992) 295-300
19. El-Lamie I.K., Shehata N.A., Abou-Loz S.K., et al. Conservative surgical management of malignant ovarian germ cell tumors: the experience of the Gynecologic Oncology Unit at Ain Shams University. Eur. J. Gynaecol. Oncol. 21 6 (2000) 605-609
20. Williams S.D., Kauderer J., Burnett A.F., et al. Adjuvant therapy of completely resected dysgerminoma with carboplatin and etoposide: a trial of the Gynecologic Oncology Group. Gynecol. Oncol. 95 3 (2004) 496-499
21. Munkarah A., et al. Salvage surgery for chemorefractory ovarian germ cell tumors. Gynecol. Oncol. 55 2 (1994) 217-223
22. Chou H.H., et al. Combination of high-dose chemotherapy, autologous bone marrow/peripheral blood stem cell transplantation, and thoracoscopic surgery in refractory nongestational choriocarcinoma of a 45XO/46XY female: a case report. Gynecol. Oncol. 64 3 (1997) 521-525
23. Gershenson D.M. Management of early ovarian cancer: germ cell and sex cord-stromal tumors. Gynecol. Oncol. 55 3 Pt 2 (1994) S62-S72
24. Williams S.D., et al. Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N. Engl. J. Med. 316 23 (1987) 1435-1440
25. Waller S., et al. Prognostic factors responsible for the survival of women with the germ cell cancers of the ovary: A study of 760 patients. Gynecol. Oncol. 101 (2006) S70 (Abstract)
26. Segelov E., et al. Cisplatin-based chemotherapy for ovarian germ cell malignancies: the Australian experience. J. Clin. Oncol. 12 2 (1994) 378-384
27. Lai C.H., et al. Outcome and prognostic factors in ovarian germ cell malignancies. Gynecol. Oncol. 96 3 (2005) 784-791
28. Baranzelli M.C., Kramar A., Bouffet E., Quintana E., Rubie H., Edan C., et al. Prognostic Factors in Children With Localized Malignant Non-seminomatous Germ Cell Tumors. J. Clin. Oncol. 17 (1999) 1212-1218
29. Culine S.B., Rey D., Lhommé A., Guastalla C., and Droz J.P. Prognostic factors for survival in chemotherapy-treated ovarian germ cell tumors. Proc. Am. Soc. Clin. Oncol. 15 (1996) 294 (abstract)
30. O'Connor D.M., and Norris H.J. The influence of grade on the outcome of stage I ovarian immature (malignant) teratomas and the reproducibility of grading. Int. J. Gynecol. Pathol. 13 4 (1994) 283-289
31. Cushing B., et al. Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: a report of the pediatric oncology group and the children's cancer group. Am. J. Obstet. Gynecol. 181 2 (1999) 353-358
32. Le Goarant de Tromelin J., et al. [Strategy for management of ovarian immature teratoma. About three cases and review]. Gynecol. Obstet. Fertil. 33 9 (2005) 594-599
33. Cheung M.M., et al. Experience with the management of ovarian germ cell tumors in Chinese patients. Gynecol. Oncol. 52 3 (1994) 306-312
34. Sagae S., and Kudo R. Surgery for germ cell tumors. Semin. Surg. Oncol. 19 1 (2000) 76-81
35. Dark G.G., et al. Surveillance policy for stage I ovarian germ cell tumors. J. Clin. Oncol. 15 2 (1997) 620-624
36. Heslan I., et al. [Immature teratoma of the ovary. Apropos of 3 cases. Review of the literature and an evaluation]. J. Gynecol. Obstet. Biol. Reprod. (Paris) 23 7 (1994) 790-796
37. Charvolin J.Y., and Querleu D. [Relevance of surgical lymph node staging for malignant ovarian germ cell tumors]. Contracept. Fertil. Sex. 27 1 (1999) 51-55
38. Low J.J., et al. Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 cases. Cancer 89 2 (2000) 391-398
39. Casey A.C., et al. Dysgerminoma: the role of conservative surgery. Gynecol. Oncol. 63 3 (1996) 352-357
40. Querleu D., Leblanc E., Cartron G., Narducci F., Ferron G., and Martel P. Audit of preoperative and early complications of laparoscopic lymph node dissection in 1000 gynecologic cancer patients. Am. J. Obstet. Gynecol. (2006) 195-1287
41. Cartron G., Leblanc E., Ferron G., et al. [Complications of laparoscopic lymphadenectomy in gynaecologic oncology. A series of 1102 procedures in 915 patients]. Gynecol. Obstet. Fertil. 33 5 (2005) 304-314
42. Rogers P.C., Olson T., Cullen J.W., Billmire D.F., Marina N., Rescorla F., et al. Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cells tumors: a Pediatric Intergroup Study-Pediatric Oncology Group 9048 and Children's Cancer Group 8891. J. Clin. Oncol. 22 (2004) 3563-3569
43. Leblanc E., Caty A., Dargent D., Querleu D., and Mazeman E. Extraperitoneal laparoscopic para-aortic lymph node dissection for early stage nonseminomatous germ cell tumors of the testis with introduction of a nerve sparing technique: description and results. J. Urol. 165 1 (2001) 89-92
44. Leblanc E, Caty A. Présentation AFU. 2005.
45. Herrin V.E., and Thigpen J.T. In: Raghavan D., et al. (Ed). Germ cell tumor of the ovary, in textbook of uncommon cancer (1999), John Wiley and sons, New York 671-680